RecruitingNCT07764094

Impact of Procedural Factors on Drug-Coated Balloon Outcomes in Coronary Artery Disease

Impact of Drug-Coated Balloon Procedural Factors on Angiographic and Clinical Outcomes of Percutaneous Coronary Intervention for De Novo Lesions: A Multicenter, Prospective, Observational Registry

Sponsor

Nanjing First Hospital, Nanjing Medical University

Enrollment

500 participants

Start Date

Sep 1, 2026

Study Type

OBSERVATIONAL

Conditions

Coronary Artery Disease Drug-coated Balloon PCI

Summary

This registry aimed to investigate drug-coated balloon procedural factors (particularly delivery time and inflation duration) to evaluate the impact on angiographic and clinical outcomes in patients undergoing percutaneous coronary intervention for de novo coronary lesions.

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a new treatment for people with coronary artery disease, drug-coated balloon, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.